APA (7th ed.) Citation

M, K., P, l. C., J, D., C, S., P, P., W, P., . . . Nagler, A. (2010). Activity and tolerability of nilotinib: A retrospective multicenter analysis of chronic myeloid leukemia patients who are imatinib resistant or intolerant. Cancer (0008543X), 116(19), 4564. https://doi.org/10.1002/cncr.25351

Chicago Style (17th ed.) Citation

M, Koren-Michowitz, et al. "Activity and Tolerability of Nilotinib: A Retrospective Multicenter Analysis of Chronic Myeloid Leukemia Patients Who Are Imatinib Resistant or Intolerant." Cancer (0008543X) 116, no. 19 (2010): 4564. https://doi.org/10.1002/cncr.25351.

MLA (9th ed.) Citation

M, Koren-Michowitz, et al. "Activity and Tolerability of Nilotinib: A Retrospective Multicenter Analysis of Chronic Myeloid Leukemia Patients Who Are Imatinib Resistant or Intolerant." Cancer (0008543X), vol. 116, no. 19, 2010, p. 4564, https://doi.org/10.1002/cncr.25351.